What is Altimmune Inc (ALT) stock price today?

Altimmune Inc (ALT) currently trades at $2.60 per share. The stock has a market capitalization of $370.80M and a P/E ratio of —x.

Is ALT stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Altimmune Inc has a Smart Value Score of 37/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Altimmune Inc's revenue and earnings?

Altimmune Inc has trailing twelve-month (TTM) revenue of $41000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.00.

ALT

Altimmune Inc

NASDAQ: ALT · HEALTHCARE · BIOTECHNOLOGY

$2.60

-1.14% today

Updated 2026-04-30

Market cap

$370.80M

P/E ratio

—

P/S ratio

9,043.90x

EPS (TTM)

$-1.00

Dividend yield

—

52W range

$3 – $8

Volume

4.1M

Market cap

$370.80M

P/E ratio

—

P/S ratio

9,043.90x

EPS (TTM)

$-1.00

Dividend yield

—

52W range

$3 – $8

Volume

4.1M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

6.3

Growth

5.0

Quality

C+

2.5

Profitability

4.0

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$18.15

+598.08%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

3 Strong Buy6 Buy1 Hold1 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 420.00% QoQ

Risks

- Thin margins at 0.00%

- Negative free cash flow $-19.45M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$-68000.00	$426000.00	$20000.00	$41000.00	$41000.00
Net income	$-84.71M	$-88.45M	$-95.06M	$-88.09M	$-27.36M
EPS	—	—	—	—	$-1.00
Free cash flow	$-62.71M	$-75.86M	$-79.85M	$-67.55M	$-19.45M
Profit margin	124,577.94%	-20,762.21%	-475,295.00%	-214,860.98%	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-06	WEAVER, GREGORY L	Buy	5,000	$3.54
2026-03-06	DURSO, JEROME BENEDICT	Buy	20,000	$3.54
2026-02-26	WEAVER, GREGORY L	Buy	259,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ALT	$370.80M	37	6.3	2.5	4.0	5.0	—	Hold
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Altimmune Inc trades at $2.60. Our Smart Value Score of 37/100 indicates the stock is weak. TTM revenue stands at $41000.00.

Frequently asked questions

What is Altimmune Inc's stock price?

Altimmune Inc (ALT) trades at $2.60.

Is Altimmune Inc overvalued?

Smart Value Score 37/100 (Grade D, Sell).

What is the price target of Altimmune Inc (ALT)?

The analyst target price is $18.15, representing +598.1% upside from the current price of $2.60.

What is Altimmune Inc's revenue?

TTM revenue is $41000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio9,043.90x

ROE-50.60%

Beta0.34

50D MA$3.67

200D MA$4.07

Shares out0.13B

Float0.12B

Short ratio—

Avg volume4.1M

Performance

1 week-18.57%

1 month-5.63%

3 months-48.18%

YTD-21.05%

1 year—

3 years—

5 years—

Compare

ALT vs LLY →ALT vs JNJ →ALT vs ABBV →Stock screener →